Halozyme Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $298k | 300k | 0.99 |
| 2024-12-31 | $272k | 285k | 0.95 |
| 2024-09-30 | $450k | 450k | 1.00 |
| 2023-09-30 | $251k | 297k | 0.84 |
| 2023-06-30 | $862k | 1.0M | 0.83 |
| 2022-12-31 | $3.3M | 3.4M | 0.97 |
| 2022-06-30 | $3.6M | 4.1M | 0.88 |
| 2022-03-31 | $3.6M | 4.1M | 0.88 |